Similar activity profiles were obtained for all three drugs on other cell types known to be largely devoid of MUC16-expression, again highlighting the similarity between Meso64-TR3 and non-targeted TR3 relative to Meso-TR3 (Figure 2B, BxPC3 pancreatic cancer). The gene discussed is MUC16; the disease is familial pancreatic carcinoma.